نتایج جستجو برای: p53 mutation

تعداد نتایج: 327328  

Jamshid Davoodi, Manouchehr Mirshahi, Marzieh Hagi-Sharifia Taghavi,

The p53 protein function is essential for the maintenance of the nontumorigenic cell phenotype. Pancreatic tumor cells show a very high frequency of p53 mutation. To determine if restoration of wild type p53 function can be used to eliminate the tumorigenic phenotype in these cells, pancreatic tumor cell lines, PANC-1 and HTB80, differing in p53 status were stably transfected with exogenous wil...

Journal: :E3S web of conferences 2021

PKC isozymes are involved in the modulation of cellular pathways related with tumor progression, acting as a suppressor or promoter. In cancer cells, PKCs mutated, and most common type is loss function. This paper focuses on effect PKCδ mutation gastric cancer. LOF occurs throughout catalytic kinase domains PKCδ, disrupting activation function kinase. domain, there various potential targets, su...

Journal: :iranian biomedical journal 0
مرضیه حقی شریفیا تقوی marzieh hagi-sharifia taghavi جمشید داوودی jamshid davoodi منوچهر میرشاهی manouchehr mirshahi

the p53 protein function is essential for the maintenance of the nontumorigenic cell phenotype. pancreatic tumor cells show a very high frequency of p53 mutation. to determine if restoration of wild type p53 function can be used to eliminate the tumorigenic phenotype in these cells, pancreatic tumor cell lines, panc-1 and htb80, differing in p53 status were stably transfected with exogenous wil...

Journal: :journal of physical & theoretical chemistry 2008
s. irani m. monajjemi s.m atyabi m. sadegizadeh m. heshmat

p53 is one of the gene that has important role in human cell cycle and in the human cancers too.models of codon substitution make it possible to separate mutational biases in the dna fromselective constraints on the protein, and offer a great advantage over amino acid models forunderstanding the evolutionary process of proteins and protein-coding dna sequences. in thiswork, we investigated abou...

Journal: :iranian journal of blood and cancer 0
mehrdad zeinalian department of genetics and molecular biology, school of medicine, isfahan university of medical sciences, isfahan, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی اصفهان (isfahan university of medical sciences)سازمان های دیگر: ala cancer prevention and control center, isfahan, iran nafiseh heidarzadeh ala cancer prevention and control center, isfahan, iran homayoun naji ala cancer prevention and control center, isfahan, iran, and department of anesthesia, nursing school, isfahan university of medical sciences, isfahan, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی اصفهان (isfahan university of medical sciences) mohammad reza sharbafchi department of psychiatry, school of medicine, isfahan university of medical sciences; isfahan, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی اصفهان (isfahan university of medical sciences)

background: breast cancer is one of the most common malignancies among iranian women; however, its clinicopathological feature is uncertain. we pioneered a genetic counseling program among patients with breast cancer and their families in isfahan. this is the first report of this program. methods: this was a descriptive cross-sectional study on women with breast cancer registered in ala cancer ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2003
Stephen L Rose Andrew D Robertson Michael J Goodheart Brian J Smith Barry R DeYoung Richard E Buller

PURPOSE Although survival with a p53 missense mutation is highly variable, p53-null mutation is an independent adverse prognostic factor for advanced stage ovarian cancer. By evaluating ovarian cancer survival based upon a structure function analysis of the p53 protein, we tested the hypothesis that not all missense mutations are equivalent. EXPERIMENTAL DESIGN The p53 gene was sequenced from...

2016
A. Koshino Y. Goto‐Koshino A. Setoguchi K. Ohno H. Tsujimoto

BACKGROUND p53 plays a key role in the apoptotic event induced by chemotherapeutic agents. Mutation of p53 gene has been observed in various spontaneous tumors in humans and is associated with a poor prognosis. p53 abnormalities have been evaluated in several tumors in dogs; however, the association of p53 gene mutation with clinical outcome in dogs with lymphoma has not been documented. HYPO...

2014
Hyung Won Kim Hak Min Lee Seung Hyun Hwang Sung Gwe Ahn Kyung-A Lee Joon Jeong

PURPOSE The p53 gene is one of the most frequently mutated genes in breast cancer. We investigated the patterns and biologic features of p53 gene mutation and evaluated their clinical significance in Korean breast cancer patients. METHODS Patients who underwent p53 gene sequencing were included. Mutational analysis of exon 5 to exon 9 of the p53 gene was carried out using polymerase chain rea...

Journal: :Gut 2003
M Miyaki T Iijima M Ohue Y Kita T Hishima T Kuroki T Iwama T Mori

During a search for causative genes in patients with concurrent multiple primary colon tumours, we found a novel case with a germline mutation of the p53 gene, from GCC (Ala) to GTC (Val) at codon 189. Of the six primary colon tumours that this patient had, one large advanced carcinoma exhibited a somatic p53 mutation and a somatic APC mutation, in addition to the germline p53 mutation. Two ear...

Journal: :Annals of Oncology 2022

The tumor suppressor p53 is inactivated by mutation in about half of all tumors, making mutant a prime target for cancer therapy. Missense mutations R248W, R273H and R248Q are included the five most frequent total lead to more than 630 000 new diagnosed cases diseases world every year. These mutations, located at or near protein-DNA interface, inactivation loss direct p53-DNA interactions, caus...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید